Studies Suggest that Immunotherapy Adds Punch to Earlier Attempts to Treat Recurrent Non-Hodgkin and Hodgkin Lymphoma
NYU Langone HealthNew drugs that harness the body’s immune system to destroy cancer cells appear to increase the effectiveness of later drug therapies for non-Hodgkin and Hodgkin lymphoma patients, new research suggests. This happens, scientists say, even for repeat drug therapies whose initial attempts failed to stop or reverse the disease.